Brittany H Scheid
Overview
Explore the profile of Brittany H Scheid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lucas A, Scheid B, Pattnaik A, Gallagher R, Mojena M, Tranquille A, et al.
Epilepsia
. 2023 Dec;
65(3):817-829.
PMID: 38148517
Objective: Clinicians use intracranial electroencephalography (iEEG) in conjunction with noninvasive brain imaging to identify epileptic networks and target therapy for drug-resistant epilepsy cases. Our goal was to promote ongoing and...
2.
Ojemann W, Scheid B, Mouchtaris S, Lucas A, LaRocque J, Aguila C, et al.
Brain Stimul
. 2023 Nov;
16(6):1709-1718.
PMID: 37979654
Background: Longitudinal EEG recorded by implanted devices is critical for understanding and managing epilepsy. Recent research reports patient-specific, multi-day cycles in device-detected epileptiform events that coincide with increased likelihood of...
3.
The seizure severity score: a quantitative tool for comparing seizures and their response to therapy
Pattnaik A, Ghosn N, Ong I, Revell A, Ojemann W, Scheid B, et al.
J Neural Eng
. 2023 Aug;
20(4).
PMID: 37531949
Epilepsy is a neurological disorder characterized by recurrent seizures which vary widely in severity, from clinically silent to prolonged convulsions. Measuring severity is crucial for guiding therapy, particularly when complete...
4.
Ojemann W, Scheid B, Mouchtaris S, Lucas A, LaRocque J, Aguila C, et al.
medRxiv
. 2023 Jul;
PMID: 37461688
Background: Longitudinal EEG recorded by implanted devices is critical for understanding and managing epilepsy. Recent research reports patient-specific, multi-day cycles in device-detected epileptiform events that coincide with increased likelihood of...
5.
Lucas A, Scheid B, Pattnaik A, Gallagher R, Mojena M, Tranquille A, et al.
medRxiv
. 2023 Jul;
PMID: 37398160
Background: Collaboration between epilepsy centers is essential to integrate multimodal data for epilepsy research. Scalable tools for rapid and reproducible data analysis facilitate multicenter data integration and harmonization. Clinicians use...
6.
Scheid B, Aradi S, Pierson R, Baldassano S, Tivon I, Litt B, et al.
Front Digit Health
. 2022 Apr;
4:874208.
PMID: 35445206
The Unified Huntington's Disease Rating Scale (UHDRS) is the primary clinical assessment tool for rating motor function in patients with Huntington's disease (HD). However, the UHDRS and similar rating scales...
7.
Xie K, Gallagher R, Conrad E, Garrick C, Baldassano S, Bernabei J, et al.
J Am Med Inform Assoc
. 2022 Feb;
29(5):873-881.
PMID: 35190834
Objective: Seizure frequency and seizure freedom are among the most important outcome measures for patients with epilepsy. In this study, we aimed to automatically extract this clinical information from unstructured...
8.
Scheid B, Bernabei J, Khambhati A, Mouchtaris S, Jeschke J, Bassett D, et al.
Epilepsia
. 2022 Jan;
63(3):652-662.
PMID: 34997577
Objective: Despite the overall success of responsive neurostimulation (RNS) therapy for drug-resistant focal epilepsy, clinical outcomes in individuals vary significantly and are hard to predict. Biomarkers that indicate the clinical...
9.
Murphy B, Scheid B, Hendricks Q, Apollo N, Litt B, Vitale F
Sensors (Basel)
. 2021 Aug;
21(15).
PMID: 34372446
A low and stable impedance at the skin-electrode interface is key to high-fidelity acquisition of biosignals, both acutely and in the long term. However, recording quality is highly variable due...
10.
Scheid B, Ashourvan A, Stiso J, Davis K, Mikhail F, Pasqualetti F, et al.
Proc Natl Acad Sci U S A
. 2021 Jan;
118(5).
PMID: 33495341
Over one third of the estimated 3 million people with epilepsy in the United States are medication resistant. Responsive neurostimulation from chronically implanted electrodes provides a promising treatment alternative to...